Search results
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 6 hours agoAlthough the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the...
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks via Yahoo Finance· 6 days agoOne should further note that...bottom half by a factor of 2 to 1. Be sure to follow all of these ...
Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
Investor's Business Daily· 23 hours ago"We continue to believe that the investment community significantly under-appreciates the unmet...
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
Zacks· 3 days agoFree Report) came out with quarterly earnings of $4.76 per share, beating the Zacks Consensus Estimate of $4.10 per share. This quarterly report represents an earnings surprise of 16.10%. Over ...
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
Zacks via Yahoo Finance· 1 day agoVertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of...
Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key
Investor's Business Daily· 2 days agoAlthough Vertex Pharmaceuticals (VRTX) is the de facto leader of the market for cystic fibrosis...
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 3 days agoAnd as a bonus to the potential upside, the stock also pays a dividend that yields 6.2%. A monopoly plus huge new markets potentially on the way Keith...
Dow Jones Futures Rise: AI Stock Palantir Plunges On Earnings; Apple 'Let Loose' Event Next
Investor's Business Daily· 1 day agoFollowing Monday's action, be sure to check out today's The Big Picture for an updated exposure...
Stocks Higher As Disney Dives On Revenue Miss
Investor's Business Daily· 1 day agoKey earnings movers include Datadog, Palantir and Vertex Pharmaceuticals.
Stocks Close Mixed; Disney Was Worst Stock On Dow
Investor's Business Daily· 23 hours agoThe stock fell sharply below its 50-day line, triggering a sell signal, and is now testing its 200-day moving average. Finally, Vertex gained 1.9% on the...
